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MaOBJECTIVES The purpose of this study was to investigate the incidence, predictive factors, and effect of post-
operative delirium (POD) among patients treated by transcatheter aortic valve replacement (TAVR).
BACKGROUND Patients undergoing operations that involve valve replacement appear at higher risk of POD than
patients subjected to coronary artery bypass surgery alone. In patients with severe aortic stenosis undergoing TAVR, little
is known regarding the potential impact of POD on the clinical outcomes.
METHODS A retrospective observational cohort study of 268 consecutive patients who underwent TAVR at our institute
was conducted. Delirium was diagnosed according to the Diagnostic and Statistical Manual of Mental Disorder, 4th
Edition criteria. The primary outcome of this study was the presence of in-hospital POD after TAVR.
RESULTS The incidence of POD after TAVR was 13.4% (n ¼ 36). Of these cases, 18 were associated with post-procedural
complications, including major vascular complications/bleeding (n ¼ 4), stroke (n ¼ 3), acute kidney injury (n ¼ 3), atrial
ﬁbrillation (n ¼ 4), and infectious disease (n ¼ 4). POD was most frequently diagnosed on the second day after TAVR
(interquartile range [IQR]: 1 to 5 days) and was associated with prolonged in-hospital stay regardless of complications
(in uncomplicated TAVR: 6 days [IQR: 5 to 10 days] vs. 5 days [IQR: 4 to 5 days]; p< 0.001; and in complicated TAVR: 9 days
[IQR: 8 to 15 days] vs. 6 days [IQR: 5 to 9 days]; p<0.001). Predictors of PODwere nontransfemoral (transapical/transaortic)
access (odds ratio [OR]: 7.74; 95% conﬁdence interval [CI]: 3.26 to 18.1), current smoking (OR: 3.99; 95% CI: 1.25 to 12.8),
carotid artery disease (OR: 3.88; 95% CI: 1.50 to 10.1), atrial ﬁbrillation (OR: 2.74; 95% CI: 1.17 to 6.37), and age (OR: 1.08;
95% CI: 1.00 to 1.17, per year increase). After a median follow-up of 16 months (IQR: 6 to 27 months), POD remained an
independent predictor of mortality in patients undergoing transfemoral TAVR compared with the nontransfemoral TAVR
(hazard ratio: 2.81; 95% CI: 1.16 to 6.83 vs. hazard ratio: 0.43; 95% Cl: 0.10 to 1.76), adjusted for possible confounders in a
time-dependent Cox-regression model (i.e., age, sex, Logistic EuroSCORE and the occurrence of complications).
CONCLUSIONS POD after TAVR has an incidence of around 13% and occurs early in the post-operative course. Nontrans-
femoralaccess is stronglyassociatedwith theoccurrenceofPOD.PatientswhodevelopPODshowprolonged in-hospital stayand
impaired long-term survival. (J AmColl Cardiol Intv 2016;9:160–8)© 2016 by the American College of Cardiology Foundation.D elirium is an acute organic brain syndromethat often complicates the post-operativecourse of cardiac surgery (1,2). The incidence
of post-operative delirium (POD) after cardiac surgery
ranges between 8% and 31% (3–7), increasing with age
to 25% to 52% in patients age $60 years (8–10) and
31% to 66% in patients age $70 years (11–13). Differ-
ences in study design and diagnostic criteria are
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easily overlooked. A hallmark of delirium is the
acute onset and ﬂuctuating course of symptoms
related to cognitive dysfunction, including decre-
ased consciousness, inattention, disorientation, and
impaired memory (1). Depending on the presence
of psychomotor disturbances, delirium can be classi-
ﬁed as either hyperactive, hypoactive, or mixed (14).
The etiology of delirium involves a complexUtrecht, the Netherlands; and the yDepartment of
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TABLE 2 Baseline Clinical Characteristics of the Total Study Population
Delirium
AB BR E V I A T I O N S
AND ACRONYM S
POD = post-operative delirium
TAVR = transcatheter aortic
valve replacement
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161interaction among predisposing factors (e.g.,
advanced age, pre-existing cognitive impairment,
and previous stroke) and precipitating factors (e.g.,
surgery, medication changes, and hospitalization) (1).
Although mostly transient, delirium is not a benign
cognitive disorder. After cardiac surgery, delirium
prolongs mechanical ventilation time (14,15) and
intensive care unit and hospital stay (7,15–17), and is
associatedwith sepsis (18) and increased perioperative
mortality (13,15). Furthermore, it negatively affects
early functional and cognitive performance (6,19,20)
and is related to increased mortality for up to 10
years (6,17,21). Moreover, delirium in general is linked
to an elevated risk of dementia (22) and dramatically
accelerates cognitive decline in Alzheimer disease
(23). Whether delirium itself can induce dementia
remains controversial, although there is evidence
supporting this theory (24).Overall
(n ¼ 268) p Value
Yes
(n ¼ 36)
No
(n ¼ 232)
Age, yrs 80  7 82  5 80  8 0.094
Male 123 (46) 17 (47) 106 (46) 0.864
BMI, kg/m2 26  4 26  4 26  4 0.830
BSA, m2 1.83  0.20 1.79  0.18 1.84  0.20 0.443
Logistic EuroSCORE 18  9 20  10 17  9 0.814
NYHA functional class III–IV 154 (60) 24 (69) 130 (58) 0.238
Recent decompensation 50 (19) 11 (31) 39 (17) 0.050
Diabetes mellitus 82 (31) 11 (31) 71 (31) 0.995
Dialyses 4 (2) 2 (6) 2 (1) 0.088
Hypertension 154 (58) 26 (72) 128 (55) 0.054
Dyslipidemia 88 (33) 15 (42) 73 (32) 0.225
Smoking status
Never smoker 180 (67) 19 (53) 161 (69) 0.048
Prior smoker 62 (23) 9 (25) 53 (23) 0.775
Current smoker 26 (10) 8 (22) 18 (8) 0.013
COPD 57 (21) 8 (22) 49 (21) 0.881
Estimated GFR, ml/min 57  22 51  24 58  21 0.571
Syncope 36 (14) 6 (17) 30 (13) 0.439
Carotid artery disease* 33 (12) 12 (33) 21 (9) 0.000
Prior stroke 35 (13) 5 (14) 30 (13) 0.795
Peripheral artery disease 62 (23) 18 (50) 44 (19) 0.000
Coronary artery disease 144 (54) 20 (56) 124 (53) 0.813
Prior myocardial infarction 49 (18) 9 (25) 40 (17) 0.262
Prior PCI 109 (41) 15 (42) 94 (41) 0.896
SEE PAGE 169Nonpharmacological strategies have shown effec-
tiveness in the prevention of delirium in surgical
patients, reducing the incidence by 30% to 40%,
resulting in less morbidity, shorter length of stay,
and reduced medical costs (25). Knowledge of the
predictive factors of POD is crucial to identify pa-
tients who are at increased risk, and most likely to
beneﬁt from preventive measures and intensiﬁed
post-operative monitoring. Numerous predictors of
POD after cardiac surgery have been identiﬁed, of
which higher age (3–5,7,11,15,26), cognitive impair-
ment (3,4,7,8,10,13), active depression (4,7,10,14),
atrial ﬁbrillation (4,5,7), and cardiopulmonary bypass
time (3,5,13,14) are most consistently reported.
Patients undergoing operations that involve valve
replacement appear at higher risk of POD than pa-
tients subjected to coronary artery bypass surgery
alone (8,27–29). Nowadays, transcatheter aortic valve
replacement (TAVR) is used as an alternative to sur-
gical aortic valve replacement (SAVR) in patients with
severe aortic stenosis (AS) who are deemed to beTABLE 1 Diagnostic Criteria for Delirium According to the
Diagnostic and Statistical Manual of Mental Disorders, 4th Edition
I Disturbance of consciousness (i.e., reduced clarity of awareness of
the environment, with reduced ability to focus, sustain, or shift
attention).
II A change in cognition (such as memory deﬁcit, disorientation,
language disturbance) or development of a perceptual
disturbance that is not better accounted for by a pre-existing,
established, or evolving dementia.
III The disturbance is developed over a short period of time
(usually hours to days) and tends to ﬂuctuate during the course
of the day.
IV Delirium is caused by the direct physiological consequences of a
general medical condition (further criteria for speciﬁc forms
of delirium caused by substance intoxication or withdrawal).inoperable or at high surgical risk (30). Char-
acterized by advanced age, frailty, and
extensive comorbidities, patients undergoing
TAVR seem particularly prone to develop
POD. Despite the potential effect of delirium
on outcomes and the vulnerability of
typical candidates for the procedure, little is known
regarding POD after TAVR. By means of this retro-
spective, descriptive study, we sought to investigate
the incidence, predictive factors, and effect of
POD among patients treated with TAVR.
METHODS
This is a retrospective single-center study. All
patients who underwent TAVR for severe native ASPrior CABG 49 (18) 6 (17) 43 (19) 0.787
Prior BAV 8 (3) 0 8 (3) 0.603
Atrial ﬁbrillation 92 (34) 17 (47) 75 (32) 0.080
Prior pacemaker implantation 21 (8) 2 (6) 19 (8) 0.749
Pulmonary hypertension 12 (5) 2 (6) 10 (4) 0.667
Active malignancy 16 (6) 1 (3) 15 (7) 0.704
Liver disease 5 (2) 1 (3) 4 (2) 0.517
Frailty 63 (24) 9 (25) 54 (23) 0.820
Values are mean  SD or n (%). *Prior or planned carotid artery intervention and/or $50%
diameter stenosis of the common carotid artery evaluated by computed tomography angiography
or Duplex investigation.
BAV ¼ balloon aortic valvuloplasty; BMI ¼ body mass index; BSA ¼ body surface area; CABG ¼
coronary artery bypass grafting; COPD¼ chronic obstructive pulmonary disease; GFR¼ glomerular
ﬁltration rate; NYHA ¼ New York Heart Association; PCI ¼ percutaneous coronary intervention.
TABLE 3 Procedural Features
Overall
(n ¼ 268)
Delirium
p Value
Yes
(n ¼ 36)
No
(n ¼ 232)
Procedural approach 0.000
TF 228 (85) 18 (50) 210 (91) 0.000
TF with general anesthesia 12 (5) 0 12 (6) 0.379
Nontransfemoral access* 40 (15) 18 (50) 22 (10) 0.000
General anesthesia 52 (19) 18 (50) 34 (15) 0.000
Balloon-expandable valve 174 (65) 27 (75) 147 (63) 0.173
Post-dilation 55 (21) 4 (11) 51 (22) 0.133
Conversion to surgery 1 (0.4) 0 1 (0.4) 1.000
Intraprocedural death 1 (0.4) 0 1 (0.4) 1.000
Radiation, mGy 683 (390–1,021) 701 (408–975) 694 (392–1,165) 0.244
Contrast volume, ml 159  51 159  59 160  50 0.847
Procedural time, min 124 (112–145) 140 (122–159) 124 (110–144) 0.014
Interventional time, min 85 (73–105) 90 (76–110) 85 (74–104) 0.330
Values are n (%), median (interquartile range), or mean  SD. *Transapical/transaortic.
TF ¼ transfemoral approach.
FIGURE 1 Time to
POD ¼ post-operativ
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162at the University Medical Center Utrecht were iden-
tiﬁed in our institutional database and included in
the study. Eligibility for TAVR was discussed by
the heart team and required the consensus of at least
1 interventional cardiologist and 1 cardiac surgeon.
Motivations to refuse SAVR in patients were high
operative risk (as assessed by logistic EuroSCORE-I
$15%) or the presence of contraindications to cardiac
surgery (e.g., porcelain aorta, frailty, or patent grafts
in proximity of the sternum). Frailty was subjectively
measured before allocating TAVR by an interventional
cardiologist and/or cardiothoracic surgeon on the basis
of the informal “eyeball test” (including cognitionOnset of POD After Transcatheter Aortic Valve Replacement
e delirium; TAVR ¼ transcatheter aortic valve replacement.function, physical weakness, and walk speed). Pa-
tients previously diagnosed with pre-cognitive
impairment were excluded. All patients gave
informed consent for the procedure, and due to the
retrospective nature of the study design, ethics com-
mittee approval was waived.
STUDY ENDPOINTS. The primary outcome of this study
was the presence of delirium on any day during the in-
hospital stay after TAVR. In case of suspected delirium
observed by the nurse or attending physician, a
delirium observational score (DOS) was used for
further assessment. The DOS combines an assessment
of the patient’s level of consciousness with an evalu-
ation of mental status, inattention, and disorganized
thinking. When scoring $3 points, a trained geriatri-
cian was consulted to establish or exclude the diag-
nosis of delirium on the basis of Diagnostic and
Statistical Manual of Mental Disorders (DSM)-IV
criteria (Table 1). If the diagnosis of delirium was
established, a standardized work-up to exclude
precipitating factors was set up (31). Other clinical
outcomes were adjudicated in compliance with the
Valve Academic Research Consortium 2 criteria (32).
Vascular complications were documented for all pro-
cedural “access sites,” deﬁned as any location tra-
versed by a guidewire, a catheter, or a sheath during
the procedure, including arteries, veins, left ventric-
ular apex, and the aorta. Post-discharge survival status
was established by contacting the Municipal Civil
Registries.
IMPLANTATION PROCEDURE. Patients were admitted
1 day before the procedure at our institution (if
they were not already admitted because of clinical
instability). Valve implantation was performed
per the transfemoral, transapical, or transaortic
approach, in order of our institutional preference,
depending on the presence of suitable access sites.
Common access techniques were used. All trans-
femoral procedures involved a fully percutaneous
technique. Conscious sedation was the default anes-
thetic method in transfemoral procedures; in
nontransfemoral TAVR, general anesthesia was
instituted. For the transfemoral approach, conscious
sedation was established by intravenous infusion of
the sedative propofol and the analgesic remifentanil.
Sedation was assessed according to the Ramsay
sedation scale and was maintained between 3 and 5.
Local anesthesia of the access sites was performed
by lidocaine inﬁltration. After the procedure, trans-
femoral patients were transferred directly to the
ward, avoiding any intensive care stay (including
the coronary care unit). Nontransfemoral patients
stayed for at least 1 night in the intensive care unit,
TABLE 4 In-Hospital Clinical Outcome
Overall
(n ¼ 268)
Delirium
p Value
Yes
(n ¼ 36)
No
(n ¼ 232)
Permanent pacemaker
implantation
29 (11) 6 (17) 23 (10) 0.247
Stroke 6 (2) 3 (8) 3 (1) 0.034
Myocardial infarction 3 (1) 1 (3) 2 (1) 0.352
Cardiac tamponade 8 (3) 4 (11) 4 (2) 0.013
Atrium ﬁbrillation 4 (2) 4 (11) 0 0.000
Infection 5 (1.9) 4 (11.1) 1 (0.4) 0.001
Any acute kidney injury 29 (11) 5 (14) 24 (10) 0.563
Acute kidney injury
stage II/III
7 (3) 3 (8) 4 (2) 0.053
Major vascular complication 20 (8) 4 (11) 16 (7) 0.323
Bleeding (any) 80 (30) 14 (39) 66 (28) 0.240
Major or life-threatening
bleeding
21 (8) 4 (11) 17 (7) 0.500
All-cause mortality 7 (3) 1 (3) 6 (3) 1.000
Values are n (%).
FIGURE 2 Post-Operative In-Hospital Stay
Abbreviations as in Figure 1.
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163followed by the surgical medium care unit and
thereafter the ward.
STATISTICAL ANALYSIS. Categorical variables are
expressed as frequencies and percentages and were
compared with the chi-square or Fisher exact test.
Continuous variables are expressed as mean and SD
if normally distributed or as median (interquartile
range [IQR]) if skewed and compared with the Student
t test or its nonparametric equivalents, respectively.
Univariable variables with p values <0.10 were
entered in the backward stepwise multivariable lo-
gistic regression to identify the pre-procedural risk
factors of POD. Collinearity diagnostics were evalu-
ated for all variables considered for multivariable
analysis. In case of multicollinearity, the variable
with the higher odds ratio (OR) was incorporated into
the model. The association between POD and mor-
tality was analyzed using Kaplan-Meier survival es-
timates and the log-rank test. To isolate the
association of POD with all-cause mortality, a Cox
regression model was developed including possible
confounders (i.e., age, sex, any post-procedural
complication, and logistic EuroSCORE). The propor-
tional hazards assumption was tested for each vari-
able by visual inspection of the log-minus-log plots.
Nonproportionality was accounted for by incorpora-
tion of time-dependent covariates. Results are re-
ported as ORs or hazard ratios (HRs), where
appropriate, with 95% conﬁdence intervals (CIs). All
tests were 2-tailed, and a p value <0.05 was consid-
ered statistically signiﬁcant. All statistical analyses
were carried out using the IBM Statistical Package for
Social Science for Windows, version 21.0 (IBM Corp.,
Armonk, New York) and GraphPad Prism, version 6
(GraphPad Software, La Jolla, California).
RESULTS
Between November 2011 and December 2014, 270 pa-
tients underwent TAVR because of severe symptom-
atic AS at the University Medical Center Utrecht. Two
patients (0.7%) were excluded because of known Alz-
heimer disease, leaving 268 patients for further anal-
ysis. There were no cases of delirium observed before
the procedure. The overall incidence of POD diagnosed
in accordance with DSM-IV criteria was 13.4% (n ¼ 36).
Baseline characteristics and procedural and hospital
outcomes of the study population stratiﬁed according
to the occurrence of POD are summarized in Tables 2 to
4. Pre-operatively, the POD versus non-POD groups
differed signiﬁcantly in the rates of carotid disease
(33% vs. 9%; p< 0.001), peripheral artery disease (50%
vs. 9%; p < 0.001), and current smoking habit (22% vs.
18%; p ¼ 0.013). Regarding procedural features,patients who developed POD more frequently under-
went nontransfemoral procedures (50% vs. 10%; p <
0.001), more frequently received general anesthesia
(50% vs. 15%; p < 0.001), and underwent longer pro-
cedures (140 min vs. 124 min; p ¼ 0.014). Concerning
clinical outcomes, stroke (8% vs. 1%; p ¼ 0.034), car-
diac tamponade (11% vs. 2%; p ¼ 0.013), post-operative
atrial ﬁbrillation (11% vs. 0%; p < 0.001), infectious
disease (11% vs. 0.4%; p ¼ 0.001), and acute kidney
injury (8% vs. 2%; p ¼ 0.053) were more prevalent in
the POD group. Of the 36 POD cases, 18 were associ-
ated with at least 1 post-procedural complication,
TABLE 5 Baseline and Procedural Predictors for POD in Univariable and
Multivariable Analysis
Univariable p Value Multivariable p Value
Age 1.04 (0.98–1.10) 0.160 1.08 (1.00–1.17) 0.041
Atrial ﬁbrillation 1.87 (0.92–3.81) 0.083 2.74 (1.17–6.37) 0.020
Carotid artery disease 5.02 (2.20–11.5) 0.000 3.88 (1.50–10.1) 0.005
Current smoker 3.39 (1.35–8.53) 0.009 3.99 (1.25–12.8) 0.020
Peripheral artery disease 4.27 (2.06–8.87) 0.000 — —
Hypertension 2.11 (0.97–4.58) 0.058 — —
Nontransfemoral access* 9.55 (4.34–21.0) 0.000 7.74 (3.26–18.1) 0.000
General anesthesia 5.82 (2.75–12.3) 0.000 — —
Values are odds ratio (95% conﬁdence interval). *Transapical or transaortic transcatheter aortic
valve replacement approach.
FIGURE 3 Kaplan-M
Transfemoral TAVR
POD ¼ post-operativ
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164including major vascular complications/bleeding
(n ¼ 4), stroke (n ¼ 3), acute kidney injury (n ¼ 3),
atrial ﬁbrillation (n ¼ 4), and infectious disease
(n ¼ 4).
Delirium was most frequently diagnosed on day 2
(IQR: 1 to 5 days) after TAVR (Figure 1) and was asso-
ciated with prolonged in-hospital stay regardless of
complications (in uncomplicated TAVR: 6 days [IQR:
5 to 10 days] vs. 5 days [IQR: 4 to 5 days]; p < 0.001;
and in complicated TAVR: 9 days [IQR: 8 to 15 days]
vs. 6 days [IQR: 5 to 9 days]; p < 0.001) (Figure 2).
Multivariable logistic regression analysis showed
that nontransfemoral access (OR: 7.74; 95% CI: 3.26 to
18.10), current smoking (OR: 3.99; 95% CI: 1.25 to
12.80), carotid artery disease (OR: 3.88; 95% CI: 1.50 to
10.10), atrial ﬁbrillation (OR: 2.74; 95% CI: 1.17
to 6.37), and age (OR: 1.08; 95% CI: 1.00 to 1.17)
were independent predictors of POD (Table 5). General
anesthesia was not incorporated in the model because
of multicollinearity with nontransfemoral access.eier Survival Curves of the Association Between POD After
and Mortality
e delirium; TAVR ¼ transcatheter aortic valve replacement.After a median follow-up of 16 months (IQR: 6 to
27 months), overall mortality was 18%. Patients who
developed POD demonstrated higher mortality in
transfemoral TAVR (39% vs. 13%; p ¼ 0.003) but not
in nontransfemoral TAVR (33% vs. 36%; p ¼ 0.841).
POD remained a signiﬁcant predictor of mortality in
transfemoral TAVR (HR: 2.81; 95% CI: 1.16 to 6.83),
but not in nontransfemoral TAVR (HR: 0.43; 95% CI:
0.10 to 1.76), independent of age, sex, logistic
EuroSCORE, and the occurrence of complications
(Online Table 1, Figures 3 and 4).
DISCUSSION
In the present study, we investigated the incidence,
predictors, and effect of POD after TAVR. The inci-
dence of POD (on the basis of DSM-IV criteria) was
13.4% in this cohort. Nontransfemoral TAVR,
increased age, carotid artery disease, current smoking
habit, and AF were independent predictors of POD.
The occurrence of POD was associated with prolonged
in-hospital stay regardless of complications and
remained an independent predictor of mortality in
transfemoral TAVR but not in nontransfemoral TAVR
when adjusted for age, sex, logistic EuroSCORE, and
the occurrence of complications.
Post-operative delirium is an outcome that
certainly deserves attention in TAVR, as the typical
target TAVR patient and several procedural aspects
of TAVR designate this intervention as “high risk” of
being complicated by delirium. Advanced age and
signiﬁcant comorbidities may predispose all TAVR
candidates to POD. Moreover, ischemic brain injury, 1
of the mechanisms suspected to cause POD through
alteration of cerebral acetylcholine levels (33), is
commonly encountered in TAVR. In cardiac surgery, a
higher microembolic load (34), elevated biomarkers of
brain tissue damage (35), and clinical cerebrovascular
events (5,10,26) have been associated with POD. In
response to brain injury, increased microglia activity
induced by neuroinﬂammation in the brain has been
hypothesized to be 1 of the mechanisms that may
contribute to POD (36). Brain injury related to TAVR
most often involves (micro)infarctions caused by
cerebral embolization of aortic plaque or valve parti-
cles dislodged during prosthesis positioning and
deployment (37). Rapid ventricular pacing may also
contribute to ischemic brain injury by causing episodic
hypotension and cerebral hypoperfusion (38).
Data on the incidence of delirium after TAVR are
scarce, as the present study is 1 of the ﬁrst on this topic.
A previous small cohort study (including patients
treated in 2008 and 2009, n ¼ 122) reported a 12%
incidence of POD after transfemoral TAVR and 53%
FIGURE 4 Kaplan-Meier Survival Curves of the Association Between POD After
Nontransfemoral TAVR and Mortality
Abbreviations as in Figure 3.
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165after transapical TAVR (39). This is in line with the
8% and 45% POD rate after transfemoral and non-
transfemoral TAVR in our analysis. Despite extensive
comorbidities, POD appears to occur substantially less
often after transfemoral TAVR (<10%) than after SAVR
in elderly patients (31% to 66%), whereas the incidence
of POD after nontransfemoral TAVR (w50%) seems to
approach that of SAVR (8,12). Recently, a non-
randomized prospective study investigating POD in
octogenarians after TAVRandSAVR reported SAVRas a
risk factor for POD, with a 22% higher incidence
compared with TAVR (12). The reported 44% rate of
POD after TAVR in this study is difﬁcult to interpret,
however, due to the absence of data on procedural
access and the use of a different diagnostic tool
(confusion assessment method) for delirium.
Similar to previous data, nontransfemoral access
was identiﬁed as the strongest predictor of POD in the
present analysis (39). A distinct feature of patients
with nontransfemoral access is the presence of
advanced vascular disease, which may be indicative
of coexisting cerebrovascular disease, creating
increased potential for intraprocedural cerebral
ischemia and POD. Otherwise, nontransfemoral pro-
cedures involve a stronger noxious stimulus than
transfemoral TAVR, due to the need for general
anesthesia, the intensive care stay, and the dis-
orienting effect of the frequent change of environ-
ment, and is therefore more likely to precipitate
delirium. Nontransfemoral access also comes with
post-operative pain, increased opioid use, and
post-operative inﬂammation, all factors capable of
triggering POD. Although signiﬁcantly associated
with POD in the univariable analysis, the indepen-
dent effect of general anesthesia could not be
assessed in the present study because of multi-
collinearity with nontransfemoral TAVR. General
anesthesia has been linked to post-operative cogni-
tive dysfunction, as general anesthetics exert an
anticholinergic effect and interfere with many neural
processes, involving intracellular calcium signaling,
receptor functioning, and gene transcription (40).
Clinical data on the relevance of anesthetic technique
(general anesthesia vs. local anesthesia  sedation)
in provoking delirium are inconclusive. However,
considering the many procedural aspects that may
promote delirium, it seems implausible that anes-
thetic technique is solely causative for the higher
rate of POD in nontransfemoral TAVR.
All remaining predictors found in this study,
including older age (3–5,7,11,15,26), carotid artery dis-
ease (5,26,41), atrial ﬁbrillation (4,5,7), and current
smoking (42), have been previously related to POD in
cardiac surgery. The common denominator of thesefactorsmay be their involvement in the causative chain
of ischemic brain injury through an association with
(cerebral) atherosclerosis or thromboembolism. Older
age is also a risk factor of POD due to an age-dependent
decrease in neurotransmitter release and overtime
accumulation of cerebral tissue damage that aggravate
susceptibly to brain dysfunction (1,43). Besides pro-
moting atherosclerosis, active smoking has been hy-
pothesized to contribute to POD by abrupt cessation
during hospitalization, because nicotine withdrawal
involves acetylcholine disturbances similar to POD
(44). Pre-operative AF not only is postulated to pre-
dispose to POD by inﬂicting thromboembolic brain
damage, but may additionally provoke periods of hy-
potension causing cerebral hypoperfusion (45).
Analogous to observations in conventional cardiac
surgery, POD after TAVR was related to an adverse
outcome in the present analysis, characterized by
prolonged in-hospital stay, and, in case of trans-
femoral TAVR, elevated follow-up mortality. Stratiﬁ-
cation according to the presence of post-operative
complications (other than delirium) demonstrated
that POD in itself leads to prolonged hospitalization
after TAVR. To what extent increased morbidity and
mortality can be truly attributed to POD is difﬁcult to
establish (46). Rather than being causally related to
adverse events, POD may reﬂect a patient’s decreased
resilience against noxious stimuli (i.e., fragility),
merely identifying those individuals already predis-
posed to worse treatment outcomes. Along similar
lines, the occurrence of POD after less physically
demanding transfemoral procedures may identify
extremely frail patients, which may explain the
higher mortality rate. Uncertainty regarding the
TABLE 6 Adapted Guidelines for Prevention of Delirium in At-Risk Adults From the National Institute for Health and Care Excellence
Pre-Operative Assessment
1 Avoid moving persons within and between wards or rooms unless absolutely necessary
2 Give a tailored, multicomponent intervention package on the basis of the risk factors for delirium
Post-Operative Care
3 Reorient the patient at risk by providing appropriate lighting and clear signage, ensuring that a clock (consider providing a 24-h
clock in the critical care unit) and a calendar are easily visible
4 Address dehydration and constipation by ensuring adequate ﬂuid intake
5 Assess for hypoxia and optimize oxygen saturation, if necessary, as clinically appropriate
6 Treat infections and avoid unnecessary catheterization
7 Promote mobility
8 Address and assess for pain
9 Carry out a medication review for persons receiving several drugs, taking into account both the type and the number of
medications
10 Address poor nutrition by following the advice given in the nutrition support in adults section in the NICE clinical guideline
11 Screen and address sensory impairment by providing hearing and visual aids
12 Promote good sleep patterns
Guidelines adapted from O’Mahony et al. (47).
NICE ¼ National Institute for Health and Care Excellence.
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166sequence of events also clouds the perception of
the true effect of POD; for example, prolonged me-
chanical ventilation has been reported as both a pre-
dictor as well as a consequence of delirium, and the
same holds true for cognitive impairment (7,9,14,15).
Nevertheless, in view of the magnitude of evidence
reporting unfavorable outcomes and increased med-
ical costs in POD, it certainly seems like an entity to
be avoided, especially in the elderly.
Primary prevention and early recognition of
delirium have demonstrated effectiveness in reducing
delirium incidence and falls. Moreover, prevention
may decrease the length of in-hospital stay, reduce
the need for institutionalization, and ultimately
reduce medical costs (1,25). The predictors identiﬁed
in this study can aid in the identiﬁcation of TAVR
patients who are at higher risk for developing POD
and who will beneﬁt most from intensiﬁed surveil-
lance and targeted prevention. Although many pre-
disposing and precipitating factors of delirium are
nonmodiﬁable, several nonpharmacological measures
can be taken to prevent POD in susceptible patients,
as summarized in Table 6 (47). Speciﬁcally, in the
TAVR setting, it seems advisable to avoid non-
transfemoral access whenever justiﬁed. To date, there
is no consensus on the efﬁcacy of pharmacological
therapy in the prevention and treatment of delirium
(1). Whether a reduction of embolic burden by cerebral
protection devices may positively affect the rate of
POD in TAVR seems speculative considering the
multifactorial nature of this cognitive disorder.
STUDY LIMITATIONS. The main limitations of this
study are related to its retrospective, single-center
design. The retrospective assessment of deliriummay have led to underestimation of the incidence of
delirium, as symptoms can be subtle, especially in the
case of the hypoactive form. Furthermore, we were
unable to reliably quantify in retrospect the presence
of pre-operative cognitive impairment and active
depression, important predictors of POD in cardiac
surgery. Finally, the relatively small sample size
(transfemoral and nontransfemoral groups) did not
allow for exhaustive multivariable analysis to fully
isolate the independent effect of deliriumon follow-up
mortality.
CONCLUSIONS
Despite their apparent susceptibility, only 1 in 8 TAVR
patients develops delirium during the post-operative
course. The incidence of POD heavily depends on
procedural access, with a 5-fold higher rate in non-
transfemoral compared with transfemoral TAVR. Be-
sides procedural access, older age; carotid artery
disease; current smoking; and pre-operative AF were
identiﬁed as independent predictors of POD. Post-
operative delirium after TAVR was associated with
prolonged in-hospital stay and increased all-cause
mortality during follow-up. Early recognition and
prevention strategies may decrease the incidence of
POD and improve outcomes in TAVR patients. Future
large prospective studies are needed to conﬁrm these
ﬁrst ﬁndings on POD after TAVR.
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PERSPECTIVES
WHAT IS KNOWN? In cardiac surgery, POD complicates
the post-operative course with prolonged in-hospital stay
and increased long-term mortality. Despite the potential
effect of delirium on outcomes after TAVR and the sus-
ceptibility of these patients, little is known regarding POD
after TAVR.
WHAT IS NEW? The incidence of POD is 13.4% in this
cohort, which is 5-fold higher in nontransfemoral TAVR
(45% vs. 8%). The baseline independent predictors of
POD are nontransfemoral TAVR, age, carotid artery dis-
ease, current smoking, and atrial ﬁbrillation. The
occurrence of POD was associated with prolonged in-
hospital stay regardless of complications, and remained
an independent predictor of mortality in a transfemoral
TAVR but not in nontransfemoral TAVR when adjusted
for age, sex, logistic EuroSCORE, and the occurrence of
complications.
WHAT IS NEXT? The predictors identiﬁed in this study
can aid the identiﬁcation of TAVR patients who are at
higher risk for developing POD and who will beneﬁt
most from intensiﬁed surveillance and targeted
prevention.
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